Studying the structure of the cone snail insulin could help researchers
modify human insulin to lose its self - aggregation but retain its potency, Safavi says.
Not exact matches
By the late 1970s Boyer's company, Genentech, was churning out
insulin for diabetics using Escherichia coli
modified to contain a synthetic
human gene.
To understand some of the techniques used in biotechnology, lets look at how bacteria have been
modified to produce
human insulin.